|
[1]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324.
|
|
[2]Isaacs A, Lindermann J.Virus interference I[J].The interferon, 1957, 147∶258.
|
|
[3] Kenji O, Paul W K, Cai Z, et al.Type I interferons and limitin:acomparison of structures, receptors, and function[J].Cytokine, Growth Factor Rev, 2001∶12337.
|
|
[4]Peska S, Langer JA.Interferons and their actions[J].Annu RevBiochem, 1987, 56∶727.
|
|
[5] Novick D, Cohen B, Rubinstein M.The human interferon alpha/beta receptor:characterization and molecular cloning[J].cell, 1994, 77∶3912400.
|
|
[6]Orchansky P, Novick D G.TypeⅠand typeⅡinterferon receptors[J].interferon Res, 1980, 4∶275.
|
|
[7]Novick D, Orchansky P, Revel M, et al.The human interferon-rreceptor, purification, characterization and preparation of antibodies[J].J BiolChem, 1987, 262∶8483.
|
|
[8] Yatsuhashi H, Fujino T, Matsumoto T, et al.Immunohistochemicalanalysis of hepatic interferon alpha/beta receptor level:relationshipbetween receptor expression and response to interferon thrapy in pa-tients with chronic C[J].hepatol, 1999, 30∶99521003.
|
|
[9]汤群, 杨金龙, 何生松, 等.HBV感染的慢性肝病患者外周血单核细胞中干扰素α/β受体表达[J].中华传染病杂志, 2004, 2∶49-51.
|